SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000892712-09-000963
Filing Date
2009-10-27
Accepted
2009-10-27 18:40:10
Documents
1
Period of Report
2009-10-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5334
  Complete submission text file 0000892712-09-000963.txt   7144
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080 650-266-3000
CELL GENESYS INC (Issuer) CIK: 0000865231 (see all company filings)

IRS No.: 943061375 | State of Incorp.: DE | Fiscal Year End: 1017
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7701 FRANCE AVENUE SOUTH SUITE 500 EDINA MN 55435
Business Address
Kopp LeRoy C (Reporting) CIK: 0001399913 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19986 | Film No.: 091140130